Susquehanna International Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-22,294
| Closed | -$41K | – | 7266 |
|
|
2022
Q4 | $41K | Buy |
+22,294
| New | +$41K | ﹤0.01% | 5216 |
|
|
2022
Q3 | – | Sell |
-1,850
| Closed | -$8K | – | 7473 |
|
|
2022
Q2 | $8K | Sell |
1,850
-2,497
| -57% | -$10.8K | ﹤0.01% | 5543 |
|
|
2022
Q1 | $45K | Buy |
4,347
+2,043
| +89% | +$21.1K | ﹤0.01% | 5331 |
|
|
2021
Q4 | $34K | Buy |
2,304
+993
| +76% | +$14.7K | ﹤0.01% | 5553 |
|
|
2021
Q3 | $39K | Buy |
+1,311
| New | +$39K | ﹤0.01% | 5123 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6292 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6120 |
|
|
2020
Q4 | – | Sell |
-70
| Closed | -$9K | – | 5539 |
|
|
2020
Q3 | $9K | Sell |
70
-280
| -80% | -$36K | ﹤0.01% | 4337 |
|
|
2020
Q2 | $59K | Buy |
350
+201
| +135% | +$33.9K | ﹤0.01% | 4001 |
|
|
2020
Q1 | $21K | Sell |
149
-514
| -78% | -$72.4K | ﹤0.01% | 4345 |
|
|
2019
Q4 | $219K | Sell |
663
-1,098
| -62% | -$363K | ﹤0.01% | 3433 |
|
|
2019
Q3 | $880K | Sell |
1,761
-61
| -3% | -$30.5K | ﹤0.01% | 2170 |
|
|
2019
Q2 | $1.11M | Buy |
1,822
+1,076
| +144% | +$654K | ﹤0.01% | 1911 |
|
|
2019
Q1 | $455K | Buy |
746
+641
| +610% | +$391K | ﹤0.01% | 1925 |
|
|
2018
Q4 | $38K | Sell |
105
-408
| -80% | -$148K | ﹤0.01% | 3372 |
|
|
2018
Q3 | $346K | Buy |
513
+449
| +702% | +$303K | ﹤0.01% | 2291 |
|
|
2018
Q2 | $56K | Sell |
64
-609
| -90% | -$533K | ﹤0.01% | 3395 |
|
|
2018
Q1 | $847K | Buy |
673
+558
| +485% | +$702K | ﹤0.01% | 1637 |
|
|
2017
Q4 | $172K | Buy |
+115
| New | +$172K | ﹤0.01% | 3196 |
|